Publikationen

2012Embo J

Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis

T Schwandt, B Schumak, G H Gielen, F Jungerkes, P Schmidbauer, K Klocke, A Staratschek-Jox, N van Rooijen, G Kraal, I Ludwig-Portugall, L Franken, S Wehner, J C Kalff, O Weber, C Kirschning, C Coch, U Kalinke, J Wenzel, C Kurts, R Zawatzky, B Holzmann, L Layland, J L Schultze, S Burgdorf, J M den Haan, P A Knolle, A Limmer

2011Nat Neurosci

Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS

A Dann, H Poeck, AL Croxford, S Gaupp, K Kierdorf, M Knust, D Pfeifer, C Maihoefer, S Endres, U Kalinke, SG Meuth, H Wiendl, KP Knobeloch, S Akira, A Waisman, G Hartmann, M Prinz

2012Immunol Cell Biol

Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS

U Kalinke, M Prinz

2012PLoS pathogens

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

M Kremer, Y Suezer, A Volz, T Frenz, M Majzoub, K M Hanschmann, M H Lehmann, U Kalinke, G Sutter

2012Blood

ICOS-LICOS interaction is critically involved in TGN1412-mediated T cell activation

S Weissmueller, L Y Semmler, U Kalinke, S Christians, J Mueller-Berghaus, Z Waibler

2011J Exp Med

Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

M S Diamond, M Kinder, H Matsushita, M Mashayekhi, G P Dunn, J M Archambault, H Lee, C D Arthur, J M White, U Kalinke, K M Murphy, R D Schreiber

2011Virulence

Host strategies against virus entry via the olfactory system.

U Kalinke, I Bechmann, C N Detje

2011Hepatology

The green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits hepatitis C virus (HCV) entry.

S Ciesek, T von Hahn, C C Colpitts, L M Schang, M Friesland, J Steinmann, M P Manns, M Ott, H Wedemeyer, P Meuleman, T Pietschmann, E Steinmann

2011Nature

Senescence surveillance of premalignant hepatocytes limits liver cancer development.

T W Kang, T Yevsa, N Woller, L Hoenicke, M Gereke, T Wuestefeld, D Dauch, A Hohmeyer, A Potapova, D Bruder, P Schirmacher, T Longerich, S Kubicka, M Ott, M Iken, T Luedde, R Rudalska, M Vucur, S Weiss, M Heikenwalder, S Khan, J Gil, M P Manns, F Tacke

2011Hepatology

MicroRNA-221 regulates FAS-induced fulminant liver failure.

A D Sharma, N Narain, E M Handel, M Iken, N Singhal, T Cathomen, M P Manns, H R Scholer, M Ott, T Cantz